The global allergy immunotherapy market share analysis is poised for significant growth, with projected sales reaching USD 1,942.1 million by 2025. This surge is driven by rising allergy prevalence, increasing awareness of immunotherapy treatments, and advancements in personalized medicine. Allergy immunotherapy, commonly known as desensitization or hypo-sensitization, offers long-term relief to allergy sufferers by modifying …